2,4-Dibromothiazole, 97.0%, 5g

Metilammina, 40% in acqua, per sintesi, 250 ml, confezione in vetro

(E)-Methyl 2-(2-((6-chloropyrimidin-4-yl)oxy)phenyl)-3-methoxyacrylate, 95.0%, 100g

tert-Butyl (2R,5R)-5-(hydroxymethyl)-2-methylpiperidine-1-carboxylate, 97%, 5g

5-Bromo-3-(trifluoromethyl)benzene-1,2-diamine, 97%, 100mg

Terbinafine hydrochloride, 95.0%, 25g

2-{[(2-fluorophenyl)sulfonyl]amino}-3-methylbutanoic acid, 95.0%, 1g

5-Isopropyl-3-phenyl-2-thioxoimidazolidin-4-one, 97%, 100mg

1H-Pyrrolo[2,3-b]pyridine, 4-chloro-3-nitro-5-(trifluoromethyl)-, 97%, 100mg

Fmoc-D-Tic-OH, 95.0%, 25g

1-Ethyl-3,5-dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 100mg

3-Acetamido-4-methyl-2-nitrobenzoic acid, 95.0%, 10g

2-chloro-5-methyl-1,3-benzoxazole, 95.0%, 250mg